Jun 30
XITO · Xenous Holdings, Inc.
$0.01
At close · Sep 28
Return incl. dividend (before tax)
Going-concern doubt
— flagged Feb 24, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The accompanying financial statements have been prepared assuming that the Company will continue as a going concern; however, the above conditions raise substantial doubt about the Company's ability to do so.”View the 10-Q filed Feb 24, 2026
Market Cap
$4.64M
Shares
760.25M
Volume · Sep 28
1000
Avg daily vol (4 sessions)
47.15K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.01
Open$0.01
Day$0.01–0.01
Available close range$0.00–0.04
Avg vol 30d26K
Short int22 · 0.0% of shares · 1.0d
Short vol100%
DataJan 2020–Sep 2026
Filing10-Q · Feb 24
The closing range uses available history since Nov 5, 2025; less than a full year is stored.
Latest documents
2026
May 12
Current report
8-K
Events of May 8
Director or officer change, or executive pay
AI summary on its way
Feb 24
Quarterly report
10-Q
FY2026 Q3, ended Dec 31
Quarterly report for FY2026 Q3
AI summary on its way
Net loss $15.52K
Diluted EPS $0.00
Feb 18
2025
Nov 17
Quarterly report
10-Q
FY2026 Q2, ended Sep 30
Quarterly report for FY2026 Q2
Net loss $15.68K
Diluted EPS $0.00
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$0
Trailing 12 months
Net income (TTM)
−$64,912
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+0.0%
Year over year
Price change (1Y)
+1.7%
Trailing year
Short interest
—
Latest settlement
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Weak
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 18.7 · elevated
Equity put/call 0.72
Technical
price trend
50 / 200-day cross
No cross
Price vs 50-day avg
−80%
below
RSI (14)
45
neutral
MACD trend
Positive
52-week position
8%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−74%
trailing
6-month return
−80%
trailing
YTD return
+7%
this year
Relative strength
−96%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
0.00% of shares out · ▬ 0.0% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
1485%
annualized · 1-yr
Max drawdown
−98%
past year
ATR
201.6%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 50-day avg
−80%
Bearish
RSI (14)
45
Neutral
MACD trend
Positive
Bullish
52-week position
8%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
No clear signal
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
0.00% of shares out · ▬ 0.0% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Price context
position in its available closing range
Range low $0
Now $0 · 8%
Range high $0
vs 50-day avg -80%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Shell Companies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
XITO
this stock
Xenous Holdings, Inc.
|
$4.64M | — | — | — | 0.0% |
|
VYLR
Vylor Inc.
|
$48.09B | — | — | — | 2.1% |
|
CLUS
Cluster Group Holdings Ltd Co
|
$8.00B | — | — | — | — |
|
DMII
Drugs Made In America Acquisition II Corp.
|
$652.61M | +3.5% | — | — | 0.0% |
|
EVAC
EQV Ventures Acquisition Corp. II
|
$606.10M | +3.4% | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionShort & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| XITO | +15.1% | -74.2% | -79.6% | +0.0% | +7.0% |
| SPY | -1.0% | -0.5% | +16.1% | -0.2% | +12.3% |
| vs SPY | +16.1% | -73.7% | -95.7% | +0.2% | -5.3% |